CRL Charles River Laboratories International, Inc. Common Stock
$288.77
मूल्य · अग 18, 2026
मौलिकता इस प्रकार है अग 5, 2026
52W रेंज
$144–$289
100% of range
विश्लेषक रेटिंग
BUY
22 analysts
मूल्य लक्ष्य
$281
P/E (TTM)
-99.2
ROE
-4.4%
शुद्ध लाभ मार्जिन
-3.6%
Charles River Laboratories International, Inc. Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
और पढ़ें
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration (FDA). The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL.
History
Charles River was founded in 1947 by Henry Foster, a young veterinarian who purchased one thousand rat cages from a Virginia farm and set up a one-person laboratory in Boston overlooking the Charles River. He supplied local researchers with laboratory animals.
In 1955, the company's headquarters were relocated to their current home in Wilmington, Massachusetts. The organization became an international entity in 1966 by opening a new animal production facility in France.
The first commercial, comprehensive genetic monitoring program was implemented by Charles River in 1981. Three years later, they were acquired by Bausch & Lomb. In 1988, the organization began creating transgenic mice and rats. In the 1990s, they began in vitro endotoxin testing. In the 1990s, Jim Foster bought Charles River back from Bausch & Lomb, and the company later went public on the New York Stock Exchange.
Charles River launched the Humane Care Imperative in 2002, designed to raise awareness and train employees on animal welfare's importance. The same year, they were named "Company of the Year" by The Boston Globe. The company introduced preconditioning services in 2005 to provide customers with study-ready animals.
In 2008, Charles River signed a ten-year contract to partner with the National Cancer Institute and opened a facility in Frederick, Maryland.
In April 2019, Charles River announced it would cease its San Diego operations, moving the breeding of rodents for testing compounds to Hollister, California.
In March 2023, the Born Free USA animal welfare organization protested against Charles River's plan to export 1,000 endangered juvenile long-tail macaques to Cambodia for testing.
Acquisitions
In 1988, Charles River purchased Specific Pathogen Antigen Free Avian Services (SPAFAS) and serologic diagnostic services Merck, Sharp, and Dohme.
Between 1996 and 2000, the company acquired Endosafe, Inc. and Sierra Biomedical.
In October 2003, Charles River Laboratories merged with Inveresk, a research company based in the United Kingdom. The company was known then as Charles River Laboratories. Inveresk specialised in clinical research and pre-clinical testing, and their main facilities are in Edinburgh, Scotland. In late 2009, Charles River sold its Clinical Services Division in Edinburgh to Quotient Bioresearch.
In 2010, Charles River Laboratories attempted to acquire WuXi PharmaTech, a China-based contract research organization, but the offer was withdrawn when the deal faced opposition from several large Charles River investors, including Relational Investors, JANA Partners, and Neuberger Berman. The proxy advisory firm RiskMetrics had also recommended that Charles River's shareholders vote against the proposed deal.
From 2008 to 2013, Charles River acquires several companies including NewLab Bioquality AG, MIR Preclinical Services, Piedmont Research Center, LLC, Cerebricon, Ltd., Accugenix, and Vital River, allowing the company to expand their research models and services portfolio to drug development and discovery markets in China.
The acquisitions of Argenta and BioFocus in 2014 allowed Charles River to establish itself as a full-service, early-stage contract research organization with integrated in vitro and in vivo capabilities from target discovery through pre-clinical development.
In July 2015, the company announced it would acquire Celsis International for $212 million.
In 2016, the company announced it was set to acquire WIL Research for approximately $585 million in cash and Blue Stream Laboratories.
In August 2017, the business announced it would acquire Brains On-Line.
In January 2018, the company announced it would acquire KWS BioTest for up to £18 million ($24.4 million). In February of the same year, Charles River announced it would acquire MPI Research for approximately $800 million in cash. The transaction was completed on April 3, 2018.
In February 2019, the company announced it would acquire Citoxlab for €448 million in cash (approximately $500 million), including the former acquisitions of the French company, AccelLAB, Atlanbio and Solvo Biotechnology. The transaction was completed on April 29. In December of the same year the business announced it would acquire HemaCare for approximately $380 million in cash.
In August 2020, the company announced it would acquire Cellero for $38 million in cash.
In January 2021, the company announced it would acquire Distributed Bio, Inc., an antibody discovery business.
In February 2021, Charles River announced it would acquire Cognate BioServices, Inc. for $875 million.
In March 2021, Charles River announced the acquisition of Retrogenix for $48 million.
In May 2021, Charles River announced the acquisition of Vigene Biosciences, a gene therapy contract development and manufacturing organization (CDMO), for $292.5 million.
In October 2021, a Japanese subsidiary of Charles River was acquired by Jackson Laboratory for $63M USD.
In April 2022, the company announced it would acquire Explora BioLabs.
In January 2023, the business announced it would acquire SAMDI Tech, Inc.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
CRL स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$288.77
मार्केट कैप
$14.21B
P/E (TTM)
-99.2
EPS (TTM)
$-2.91
राजस्व (TTM)
$4.02B
लाभांश प्रतिफल
—
ROE
-4.4%
D/E ऋण/इक्विटी
0.0
52W रेंज
$144 – $289
CRL स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
Configure
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व और शुद्ध आय
$4.02B
2016-12-31
→
2025-12-27
EPS
$-2.91
2016-12-31
→
2025-12-27
फ्री कैश फ्लो
$518M
2016-12-31
→
2025-12-27
मार्जिन
-3.6%
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
मेट्रिक
5Y रुझान
CRL
सहकर्मी माध्यिका
P/E (TTM)
-99.2
39.9
P/S (TTM)
3.5
5.6
P/B
4.5
4.1
EV / EBITDA
32.7
—
Price / FCF (मूल्य / FCF)
27.4
—
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
मेट्रिक
5Y रुझान
CRL
सहकर्मी माध्यिका
Operating Margin (परिचालन मार्जिन)
0.63%
—
Net Profit Margin (शुद्ध लाभ मार्जिन)
-3.6%
11.7%
ROA
-2.0%
4.7%
ROE
-4.4%
8.5%
ROIC
1.1%
—
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
मेट्रिक
5Y रुझान
CRL
सहकर्मी माध्यिका
Debt / Equity (ऋण / इक्विटी)
0.0
15.3
Current Ratio (वर्तमान अनुपात)
1.3
1.7
Quick Ratio (त्वरित अनुपात)
0.8
—
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
मेट्रिक
5Y रुझान
CRL
सहकर्मी माध्यिका
Revenue YoY (राजस्व YoY)
-0.85%
—
Revenue CAGR 3Y (राजस्व CAGR 3Y)
0.33%
—
Revenue CAGR 5Y (राजस्व CAGR 5Y)
6.6%
—
EPS YoY
-97.8%
—
Net Income YoY (शुद्ध आय YoY)
-95.3%
—
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
मेट्रिक
5Y रुझान
CRL
सहकर्मी माध्यिका
CRL विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
खरीदें
22 विश्लेषक
- मजबूत खरीद 5 22.7%
- खरीदें 10 45.5%
- होल्ड 7 31.8%
- बेचें 0 0.0%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
14 विश्लेषक · 2026-08-14
मध्यिका
$300.00
माध्य
$281.00
अभी
$288.77
निम्न
$145.00
उच्च
$318.00
मध्यिका लक्ष्य
$300.00
+3.9%
माध्य लक्ष्य
$281.00
-2.7%
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
0.21%
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $3.02 | $2.76 | 0.26% |
| 31 मार्च 2026 | $2.06 | $1.96 | 0.10% |
| 31 दिसमबर 2025 | $2.39 | $2.37 | 0.02% |
| 30 सितमबर 2025 | $2.43 | $2.36 | 0.07% |
| 30 जून 2025 | $3.12 | $2.52 | 0.60% |
| 31 मार्च 2025 | $2.34 | $2.10 | 0.24% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | — |
| TECH | $7.97B | 111.8 | 5.2% | 6.0% | 3.7% | 64.8% |
| BIO | — | — | — | — | — | — |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 15
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.30B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $290M | $277M | $264M | $266M | |
| SG&A Expense | $743M | $751M | $748M | $665M | $620M | $529M | $518M | $444M | $371M | $365M | $300M | $269M | |
| Operating Income | $25M | $227M | $617M | $651M | $590M | $433M | $351M | $331M | $288M | $238M | $206M | $178M | |
| Interest Expense | · | · | $137M | $59M | $74M | $86M | $61M | $64M | $30M | $28M | $15M | $12M | |
| Interest Income | $5M | $9M | $5M | $780.0K | $652.0K | $834.0K | $2M | $812.0K | $690.0K | $1M | $1M | $1M | |
| Other Non-op | $-23M | $-17M | $96M | $31M | $-36M | $100M | $12M | $13M | $38M | $12M | $3M | $11M | |
| Pretax Income | $-100M | $93M | $581M | $623M | $481M | $447M | $304M | $282M | $297M | $223M | $195M | $178M | |
| Income Tax | $43M | $68M | $101M | $130M | $82M | $82M | $50M | $54M | $171M | $67M | $43M | $48M | |
| Net Income | $-144M | $22M | $475M | $486M | $391M | $364M | $252M | $226M | $123M | $155M | $149M | $127M | |
| EPS (Basic) | $-2.91 | $0.20 | $9.27 | $9.57 | $7.77 | $7.35 | $5.17 | $4.72 | $2.60 | $3.29 | $3.21 | $2.72 | |
| EPS (Diluted) | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 | |
| Shares (Basic) | 49,564,000 | 51,380,000 | 51,227,000 | 50,812,000 | 50,293,000 | 49,550,000 | 48,730,000 | 47,947,000 | 47,481,000 | 47,014,000 | 46,496,000 | 46,627,000 | |
| Shares (Diluted) | 49,564,000 | 51,628,000 | 51,451,000 | 51,301,000 | 51,425,000 | 50,611,000 | 49,693,000 | 49,018,000 | 48,564,000 | 47,958,000 | 47,634,000 | 47,558,000 | |
| EBITDA | $428M | $589M | $931M | $955M | $855M | $668M | $549M | $493M | $419M | $364M | $301M | $274M |
बैलेंस शीट 30
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $214M | $195M | $277M | $234M | $241M | $228M | $238M | $195M | $164M | $118M | $118M | $160M | |
| Short-term Investments | · | · | · | · | $1M | $1M | $941.0K | $885.0K | $28M | $4M | $21M | · | |
| Receivables | $709M | $721M | $780M | $752M | $643M | $618M | $514M | $472M | $430M | $364M | $270M | $258M | |
| Inventory | $299M | $279M | $380M | $256M | $199M | $186M | $161M | $128M | $115M | $96M | $94M | $89M | |
| Prepaid Expense | $129M | $106M | $83M | $108M | $97M | $73M | $56M | $49M | $81M | $45M | $47M | $45M | |
| Other Current Assets | · | · | · | · | · | $0 | $300.0K | $300.0K | $0 | $45M | $47M | $73M | |
| Current Assets | $1.45B | $1.40B | $1.61B | $1.44B | $1.27B | $1.20B | $1.02B | $898M | $827M | $657M | $559M | $579M | |
| PP&E (Net) | $1.66B | $1.60B | $1.64B | $1.47B | $1.29B | $1.12B | $1.04B | $933M | $782M | $756M | $678M | $677M | |
| PP&E (Gross) | $3.19B | $3.06B | $2.98B | $2.63B | $2.39B | $2.21B | $2.02B | $1.81B | $1.58B | $1.46B | $1.32B | $1.33B | |
| Accum. Depreciation | $1.54B | $1.45B | $1.34B | $1.16B | $1.10B | $1.09B | $978M | $874M | $801M | $706M | $645M | $655M | |
| Goodwill | $2.76B | $2.85B | $3.10B | $2.85B | $2.71B | $1.81B | $1.54B | $1.25B | $805M | $788M | $439M | $321M | |
| Intangibles | $340M | $723M | $864M | $955M | $1.06B | $788M | $689M | $611M | $370M | $394M | $281M | $281M | |
| Other Non-current Assets | $293M | $278M | $309M | $148M | $152M | $353M | $213M | $144M | $124M | $88M | $72M | $73M | |
| Total Assets | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B | $1.87B | |
| Accounts Payable | $149M | $140M | $169M | $206M | $198M | $122M | $111M | $66M | $78M | $68M | $37M | $34M | |
| Accrued Liabilities | $270M | $232M | $228M | $220M | $229M | $150M | $139M | $107M | $90M | $84M | $89M | $67M | |
| Current Liabilities | $1.12B | $994M | $1.06B | $1.09B | $1.03B | $840M | $710M | $558M | $464M | $430M | $312M | $295M | |
| Capital Leases | $434M | $484M | $419M | $390M | $253M | $156M | $116M | · | · | · | · | · | |
| Deferred Tax | $95M | $107M | $191M | $216M | $240M | $217M | $167M | $144M | $90M | $56M | $48M | $23M | |
| Other Non-current Liabilities | $138M | $195M | $223M | $175M | $243M | $205M | $183M | $179M | $195M | $159M | $89M | $100M | |
| Total Liabilities | $3.92B | $4.02B | $4.54B | $4.58B | $4.43B | $3.35B | $3.03B | $2.52B | $1.87B | $1.86B | $1.30B | $1.17B | |
| Long-term Debt | · | · | · | · | · | · | · | $1.61B | $1.09B | $1.18B | $814M | $717M | |
| Total Debt | $166.0K | $155.0K | $3M | $1M | $101.0K | $47M | $36M | $1.65B | $1.12B | $1.21B | $836M | $754M | |
| Common Stock | $492.0K | $511.0K | $513.0K | $509.0K | $505.0K | $498.0K | $489.0K | $482.0K | $875.0K | $863.0K | $855.0K | $845.0K | |
| Retained Earnings | $1.39B | $1.81B | $1.89B | $1.43B | $981M | $625M | $280M | $42M | $289M | $165M | $11M | $-139M | |
| Treasury Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $55.0K | $1.66B | $1.55B | $1.54B | $1.42B | |
| AOCI | $-172M | $-317M | $-196M | $-262M | $-165M | $-139M | $-178M | $-173M | $-145M | $-254M | $-136M | $-74M | |
| Stockholders' Equity | $3.16B | $3.46B | $3.60B | $2.98B | $2.53B | $2.11B | $1.63B | $1.32B | $1.05B | $837M | $733M | $672M | |
| Liabilities + Equity | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B | $1.87B | |
| Shares Outstanding | 49,217,000 | 51,141,000 | 51,338,000 | 50,944,000 | 50,480,000 | 49,767,000 | 48,936,000 | 48,209,000 | 47,402,000 | 47,363,000 | 46,698,000 | 47,327,000 |
नकदी प्रवाह 18
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $403M | $362M | $314M | $304M | $266M | $235M | $198M | $162M | $131M | $127M | $95M | $96M | |
| Stock-based Comp | $71M | $70M | $72M | $74M | $71M | $56M | $57M | $47M | $44M | $44M | $40M | $31M | |
| Deferred Tax | $-75M | $-67M | $-51M | $-33M | $-20M | $2M | $-21M | $-10M | $28M | $3M | $4M | $9M | |
| Amort. of Intangibles | $179M | $138M | $137M | $147M | $125M | $112M | $90M | $65M | $41M | $42M | $24M | $26M | |
| Restructuring | $100M | $107M | $30M | $8M | $7M | $13M | $14M | $10M | $5M | $18M | $8M | $8M | |
| Other Non-cash | $483M | $348M | $-126M | $-211M | $53M | $-111M | $-5M | $16M | $-8M | $-28M | $-395.0K | · | |
| Operating Cash Flow | $738M | $735M | $684M | $620M | $761M | $547M | $481M | $441M | $318M | $317M | $307M | $252M | |
| CapEx | $219M | $233M | $319M | $325M | $229M | $167M | $141M | $140M | $82M | $55M | $63M | $57M | |
| Investing Cash Flow | $-209M | $-245M | $-563M | $-608M | $-1.44B | $-602M | $-682M | $-955M | $-73M | $-693M | · | · | |
| Debt Issued | $1.23B | $1.08B | $776M | $2.95B | $6.95B | $2.23B | $3.36B | $2.76B | $237M | $1.04B | · | · | |
| Net Debt Issued | $1.23B | $1.08B | $776M | $2.95B | $6.95B | $2.23B | $3.36B | $2.76B | · | · | · | · | |
| Stock Repurchased | $361M | $119M | $24M | $39M | $41M | $24M | $18M | $14M | $107M | $12M | $117M | $122M | |
| Net Stock Activity | $-361M | $-119M | $-24M | $-39M | $-41M | $-24M | $-18M | $-14M | $-107M | $-12M | $-117M | $-122M | |
| Financing Cash Flow | $-537M | $-551M | $-86M | $-42M | $673M | $47M | $232M | $558M | $-208M | $381M | · | · | |
| Net Change in Cash | $10M | $-79M | $43M | $-5M | $13M | $-7M | $43M | $31M | $46M | $-69.0K | $-43M | $4M | |
| Taxes Paid | $120M | $126M | $90M | $76M | $75M | $60M | $54M | $68M | · | · | · | · | |
| Free Cash Flow | $518M | $502M | $365M | $295M | $532M | $380M | $340M | $301M | $236M | $245M | $225M | $195M | |
| Levered FCF | · | · | $252M | $248M | $471M | $309M | $290M | $250M | $223M | $226M | $213M | $186M |
लाभप्रदता 7
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 0.63% | 5.6% | 14.9% | 16.4% | 16.7% | 14.8% | 13.4% | 14.6% | 15.5% | 14.1% | 15.1% | 13.7% | |
| Net Margin | -3.6% | 0.55% | 11.5% | 12.2% | 11.0% | 12.5% | 9.6% | 10.0% | 6.6% | 9.2% | 10.9% | · | |
| Pretax Margin | -2.5% | 2.3% | 14.1% | 15.7% | 13.6% | 15.3% | 11.6% | 12.4% | 16.0% | 13.3% | 14.3% | 13.7% | |
| EBITDA Margin | 10.7% | 14.5% | 22.6% | 24.0% | 24.2% | 22.8% | 20.9% | 21.8% | 22.5% | 21.6% | 22.1% | 21.1% | |
| ROA | -2.0% | 0.28% | 6.0% | 6.7% | 6.2% | 7.1% | 5.9% | 6.7% | 4.4% | 6.5% | 7.6% | · | |
| ROE | -4.4% | 0.63% | 14.4% | 17.6% | 16.8% | 19.4% | 17.1% | 19.2% | 13.1% | 19.7% | 21.2% | · | |
| ROIC | 1.1% | 1.8% | 14.2% | 17.3% | 19.3% | 16.4% | 17.6% | 9.0% | 5.6% | 8.1% | 10.2% | 9.1% |
तरलता और शोधन क्षमता 5
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | 1.5 | 1.3 | 1.2 | 1.4 | 1.4 | 1.6 | 1.8 | 1.5 | 1.8 | 2.0 | |
| Quick Ratio | 0.8 | 0.9 | 1.0 | 0.9 | 0.9 | 1.0 | 1.1 | 1.2 | 1.3 | 1.1 | 1.2 | 1.4 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 1.1 | 1.4 | 1.1 | 1.1 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 1.2 | 1.0 | 1.4 | 1.1 | 1.1 | |
| Interest Coverage | · | · | 4.5 | 11.0 | 8.0 | 5.0 | 5.8 | 5.2 | 9.7 | 8.6 | 13.7 | 14.9 |
दक्षता 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 2.7 | 2.9 | 2.9 | 3.0 | |
| Receivables Turnover | 5.6 | 5.4 | 5.4 | 5.7 | 5.6 | 5.2 | 5.3 | 5.0 | 4.7 | 5.3 | 5.2 | 5.4 |
विकास दरें 7
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.85% | -1.9% | 3.9% | 12.3% | 21.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.33% | 4.6% | 12.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | -97.8% | -2.7% | 24.7% | 5.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -70.3% | 8.6% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | -95.3% | -2.4% | 24.4% | 7.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -61.6% | 9.2% | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 14
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.30B | |
| Net Income TTM | $-144M | $22M | $475M | $486M | $391M | $364M | $252M | $226M | $123M | $155M | $149M | $127M | |
| Market Cap | $10.02B | $9.52B | $12.14B | $11.10B | $18.64B | $12.53B | $7.43B | $5.39B | $5.19B | $3.61B | $3.74B | $3.04B | |
| Enterprise Value | $9.81B | $9.33B | $11.86B | $10.87B | $18.40B | $12.34B | $7.23B | $6.84B | $6.12B | $4.70B | $4.46B | $3.64B | |
| P/E | -70.0 | 930.8 | 25.6 | 23.0 | 48.6 | 35.0 | 30.0 | 24.2 | 43.1 | 23.6 | 25.6 | 24.2 | |
| P/S | 2.5 | 2.4 | 2.9 | 2.8 | 5.3 | 4.3 | 2.8 | 2.4 | 2.8 | 2.1 | 2.7 | 2.3 | |
| P/B | 3.2 | 2.8 | 3.4 | 3.7 | 7.4 | 5.9 | 4.5 | 4.1 | 5.0 | 4.3 | 5.1 | 4.5 | |
| P / Tangible Book | 166.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 13.6 | 13.0 | 17.7 | 17.9 | 24.5 | 22.9 | 15.5 | 12.2 | 16.3 | 12.0 | 13.0 | 12.1 | |
| P / FCF | 19.3 | 19.0 | 33.2 | 37.6 | 35.0 | 33.0 | 21.8 | 17.9 | 22.0 | 14.7 | 16.6 | 15.6 | |
| EV / EBITDA | 22.9 | 15.8 | 12.7 | 11.4 | 21.5 | 18.5 | 13.2 | 13.9 | 14.6 | 12.9 | 14.8 | 13.3 | |
| EV / FCF | 18.9 | 18.6 | 32.5 | 36.9 | 34.6 | 32.5 | 21.2 | 22.7 | 26.0 | 19.2 | 19.8 | 18.6 | |
| EV / Revenue | 2.4 | 2.3 | 2.9 | 2.7 | 5.2 | 4.2 | 2.8 | 3.0 | 3.3 | 2.8 | 3.3 | 2.8 | |
| Earnings Yield | -1.4% | 0.11% | 3.9% | 4.3% | 2.1% | 2.9% | 3.3% | 4.1% | 2.3% | 4.2% | 3.9% | 4.1% |
आय विवरण 14
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.00B | $996M | $994M | $1.00B | $1.03B | $984M | $1.00B | $1.01B | $1.03B | $1.01B | $1.01B | $1.03B | $1.03B | $1.10B | $989M | |
| Cost of Revenue | · | · | · | · | · | · | · | $661M | $672M | $667M | · | $665M | $652M | · | · | |
| SG&A Expense | $229M | $159M | $196M | $178M | $192M | $178M | $196M | $199M | $170M | $186M | $197M | $176M | $175M | $200M | $184M | |
| Operating Income | $120M | $120M | $-283M | $134M | $100M | $75M | $-168M | $117M | $152M | $126M | $133M | $152M | $168M | $164M | $151M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $35M | · | $34M | $34M | · | $11M | |
| Interest Income | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $3M | $2M | $2M | $1M | $806.0K | $343.0K | $122.0K | |
| Other Non-op | $-37M | $-124M | $12M | $-23M | $154.0K | $-12M | $-23M | $3M | $-2M | $6M | $108M | $-6M | $-3M | $116M | $-17M | |
| Income Tax | $54M | $-15M | $-18M | $32M | $19M | $10M | $-3M | $21M | $25M | $25M | $20M | $25M | $27M | $56M | $25M | |
| Net Income | $-1M | $-15M | $-277M | $54M | $52M | $25M | $-214M | $70M | $94M | $73M | $187M | $87M | $103M | $187M | $96M | |
| EPS (Basic) | $-0.03 | $-0.30 | $-5.58 | $1.11 | $1.06 | $0.50 | $-4.20 | $1.34 | $1.75 | $1.31 | $3.65 | $1.70 | $2.02 | $3.68 | $1.90 | |
| EPS (Diluted) | $-0.03 | $-0.30 | $-5.57 | $1.10 | $1.06 | $0.50 | $-4.17 | $1.33 | $1.74 | $1.30 | $3.64 | $1.69 | $2.01 | $3.66 | $1.88 | |
| Shares (Basic) | 48,021,000 | 48,951,000 | -99,475,000 | 49,213,000 | 49,149,000 | 50,677,000 | -103,002,000 | 51,394,000 | 51,551,000 | 51,437,000 | 28,000 | 51,283,000 | 51,097,000 | -101,521,000 | 50,870,000 | |
| Shares (Diluted) | 48,021,000 | 48,951,000 | -100,031,000 | 49,426,000 | 49,316,000 | 50,853,000 | -103,643,000 | 51,583,000 | 51,846,000 | 51,842,000 | -42,000 | 51,607,000 | 51,428,000 | -102,590,000 | 51,283,000 | |
| EBITDA | $187M | $187M | · | $219M | $220M | $195M | · | $206M | $238M | $211M | · | $230M | $245M | · | $226M |
बैलेंस शीट 28
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $192M | $192M | $214M | $207M | $183M | $229M | $195M | $210M | $179M | $327M | · | $157M | $202M | · | $194M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $950.0K | |
| Receivables | $712M | $700M | $709M | $734M | $768M | $757M | $721M | $754M | $762M | $787M | · | $799M | $788M | · | $771M | |
| Inventory | $346M | $360M | $299M | $303M | $280M | $290M | $279M | $336M | $349M | $361M | · | $293M | $263M | · | $262M | |
| Prepaid Expense | $179M | $135M | $129M | $166M | $130M | $100M | $106M | $102M | $111M | $99M | · | $93M | $92M | · | $97M | |
| Current Assets | $1.53B | $1.49B | $1.45B | $1.53B | $1.47B | $1.51B | $1.40B | $1.49B | $1.50B | $1.67B | · | $1.44B | $1.45B | · | $1.42B | |
| PP&E (Net) | $1.49B | $1.51B | $1.66B | $1.59B | $1.61B | $1.59B | $1.60B | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | $2.96B | $2.94B | $3.19B | $3.09B | $3.10B | $3.05B | $3.06B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $1.46B | $1.43B | $1.54B | $1.50B | $1.50B | $1.46B | $1.45B | · | · | · | · | · | · | · | · | |
| Goodwill | $3.08B | $3.04B | $2.76B | $2.92B | $2.94B | $2.87B | $2.85B | $3.12B | $3.08B | $3.07B | · | $2.88B | $2.90B | · | $2.78B | |
| Intangibles | $253M | $249M | $340M | $571M | $602M | $656M | $723M | $778M | $800M | $828M | · | $886M | $958M | · | $968M | |
| Other Non-current Assets | $588M | $826M | $293M | $291M | $296M | $294M | $278M | $307M | $301M | $303M | · | $155M | $154M | · | $430M | |
| Total Assets | $7.53B | $7.73B | $7.14B | $7.51B | $7.56B | $7.58B | $7.53B | $8.00B | $7.95B | $8.15B | · | $7.61B | $7.70B | · | $7.38B | |
| Accounts Payable | $141M | $134M | $149M | $170M | $146M | $149M | $140M | $136M | $133M | $130M | · | $136M | $120M | · | $182M | |
| Accrued Liabilities | $380M | $372M | $270M | $229M | $232M | $242M | $232M | $208M | $192M | $191M | · | $198M | $221M | · | $197M | |
| Current Liabilities | $1.13B | $1.09B | $1.12B | $1.12B | $1.08B | $1.05B | $994M | $1.01B | $948M | $955M | · | $994M | $981M | · | $1.01B | |
| Capital Leases | $408M | $393M | $434M | $443M | $454M | $475M | $484M | $433M | $429M | $418M | · | $390M | $418M | · | $369M | |
| Deferred Tax | $79M | $81M | $95M | $123M | $109M | $107M | $107M | $168M | $165M | $180M | · | $185M | $212M | · | $196M | |
| Other Non-current Liabilities | $403M | $511M | $138M | $189M | $185M | $196M | $195M | $237M | $225M | $235M | · | $173M | $187M | · | $195M | |
| Total Liabilities | $4.64B | $4.74B | $3.92B | $4.06B | $4.16B | $4.34B | $4.02B | $4.18B | $4.18B | $4.45B | · | $4.26B | $4.54B | · | $4.71B | |
| Total Debt | $5M | $7M | · | $54.0K | $98.0K | $121.0K | · | $157.0K | $435.0K | $459.0K | · | $797.0K | · | · | $0 | |
| Common Stock | $496.0K | $493.0K | $492.0K | $514.0K | $513.0K | $512.0K | $511.0K | $517.0K | $517.0K | $515.0K | · | $514.0K | $512.0K | · | $510.0K | |
| Retained Earnings | $1.37B | $1.37B | $1.39B | $1.94B | $1.89B | $1.84B | $1.81B | $2.12B | $2.05B | $1.96B | · | $1.72B | $1.54B | · | $1.28B | |
| Treasury Stock | $323M | $210M | $0 | $363M | $363M | $357M | $0 | $120M | $18M | $9M | · | $24M | $19M | · | $38M | |
| AOCI | $-196M | $-191M | $-172M | $-192M | $-166M | $-265M | $-317M | $-193M | $-270M | $-250M | · | $-268M | $-239M | · | $-396M | |
| Stockholders' Equity | $2.84B | $2.94B | $3.16B | $3.41B | $3.35B | $3.19B | $3.46B | $3.78B | $3.72B | $3.64B | · | $3.31B | $3.11B | · | $2.63B | |
| Liabilities + Equity | $7.53B | $7.73B | $7.14B | $7.51B | $7.56B | $7.58B | $7.53B | $8.00B | $7.95B | $8.15B | · | $7.61B | $7.70B | · | $7.38B | |
| Shares Outstanding | 47,728,000 | 48,167,000 | 49,217,000 | 49,215,000 | 49,209,000 | 49,115,000 | 51,141,000 | 51,134,000 | 51,613,000 | 51,510,000 | · | 51,296,000 | 51,182,000 | 50,944,000 | 50,877,000 |
नकदी प्रवाह 16
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $67M | $67M | $78M | $85M | $120M | $120M | $102M | $88M | $86M | $85M | $81M | $79M | $77M | $78M | $75M | |
| Stock-based Comp | $20M | $22M | $18M | $23M | $17M | $13M | $17M | $19M | $17M | $17M | $20M | $23M | $13M | $22M | $22M | |
| Amort. of Intangibles | $15M | $15M | $21M | $27M | $65M | $65M | $41M | $32M | $32M | $33M | $34M | $34M | $35M | $35M | $36M | |
| Restructuring | $23M | $32M | $26M | $17M | $32M | $24M | $41M | $31M | $18M | $17M | $8M | $15M | $3M | $4M | $1M | |
| Other Non-cash | · | $-34M | · | · | · | $13M | · | · | · | $-45M | · | · | $-84M | · | · | |
| Operating Cash Flow | $180M | $41M | $148M | $214M | $205M | $172M | $159M | $252M | $194M | $130M | $221M | $205M | $109M | $235M | $133M | |
| CapEx | $31M | $56M | $89M | $36M | $35M | $59M | $76M | $39M | $39M | $79M | $78M | $66M | $107M | $89M | $72M | |
| Investing Cash Flow | $28M | $-408M | $-93M | $-34M | $-37M | $-45M | $-76M | $-21M | $-62M | $-86M | $-238M | $-80M | $-169M | $44M | $-92M | |
| Debt Issued | $353M | $912M | $157M | $107M | $547M | $416M | $105M | $236M | $440M | $301M | $443M | $51M | $192M | $154M | $618M | |
| Net Debt Issued | · | $912M | · | · | · | $416M | · | · | · | $301M | · | · | $192M | · | · | |
| Stock Repurchased | $116M | $208M | $96.0K | $93.0K | $7M | $353M | $124.0K | $101M | $9M | $9M | $139.0K | $38.0K | $19M | $159.0K | $24.0K | |
| Net Stock Activity | · | $-208M | · | · | · | $-353M | · | · | · | $-9M | · | · | $-19M | · | · | |
| Financing Cash Flow | $-165M | $348M | $-52M | $-153M | $-227M | $-105M | $-76M | $-208M | $-286M | $18M | $124M | $-163M | $25M | $-249M | $-52M | |
| Net Change in Cash | $42M | $-18M | $7M | $24M | $-47M | $26M | $-6M | $31M | $-158M | $54M | $119M | $-43M | $-32M | $45M | $-11M | |
| Taxes Paid | $16M | $2M | $27M | $19M | $57M | $17M | $31M | $23M | $53M | $19M | $15M | $14M | $14M | · | · | |
| Free Cash Flow | · | $-15M | · | · | · | $112M | · | · | · | $51M | · | · | $3M | · | · |
लाभप्रदता 5
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | 12.0% | · | 13.3% | 9.7% | 7.6% | · | 11.6% | 14.8% | 12.4% | · | 14.8% | 16.3% | · | 15.3% | |
| Net Margin | -0.15% | -1.5% | · | 5.4% | 5.1% | 2.6% | · | 6.9% | 9.2% | 7.2% | · | 8.5% | 10.0% | · | 9.8% | |
| EBITDA Margin | 18.6% | 18.8% | · | 21.8% | 21.3% | 19.8% | · | 20.4% | 23.2% | 20.9% | · | 22.4% | 23.8% | · | 22.8% | |
| ROA | -0.02% | -0.19% | · | 0.70% | 0.67% | 0.32% | · | 0.89% | 1.2% | 0.92% | · | 1.2% | · | · | 1.3% | |
| ROE | -0.05% | -0.48% | · | 1.5% | 1.5% | 0.75% | · | 2.0% | 2.7% | 2.2% | · | 2.9% | · | · | 3.8% |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 1.5 | · | · | 1.4 | |
| Quick Ratio | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.9 | · | 1.0 | 1.0 | 1.2 | · | 1.0 | · | · | 1.0 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.6 | · | 4.5 | 4.9 | · | 13.3 |
दक्षता 3
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 2.1 | 2.1 | 2.1 | · | · | · | · | · | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.4 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | · | · | 1.4 |
मूल्यांकन (TTM) 13
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.04B | $4.02B | · | $4.03B | $4.05B | $4.03B | · | $4.07B | $4.12B | $4.13B | · | $4.11B | $3.91B | · | $3.77B | |
| Net Income TTM | $90M | $117M | · | $202M | $242M | $262M | · | $324M | $351M | $360M | · | $384M | $402M | · | $402M | |
| Market Cap | $10.30B | $7.67B | · | $7.31B | $7.38B | $7.64B | · | $10.14B | $10.66B | $13.96B | · | $10.05B | · | · | $9.54B | |
| Enterprise Value | $10.11B | $7.48B | · | $7.10B | $7.20B | $7.41B | · | $9.93B | $10.48B | $13.63B | · | $9.90B | · | · | $9.35B | |
| P/E | 117.9 | 67.4 | · | 37.2 | 32.4 | 31.9 | · | 32.7 | 31.2 | 39.3 | · | 26.2 | 25.8 | · | 23.9 | |
| P/S | 2.6 | 1.9 | · | 1.8 | 1.8 | 1.9 | · | 2.5 | 2.6 | 3.4 | · | 2.4 | · | · | 2.5 | |
| P/B | 3.6 | 2.6 | · | 2.1 | 2.2 | 2.4 | · | 2.7 | 2.9 | 3.8 | · | 3.0 | · | · | 3.6 | |
| P / Cash Flow | · | 186.6 | · | · | · | 44.5 | · | · | · | 107.5 | · | · | · | · | · | |
| P / FCF | · | -516.9 | · | · | · | 68.0 | · | · | · | 275.0 | · | · | · | · | · | |
| EV / EBITDA | 54.0 | 40.0 | · | 32.4 | 32.8 | 38.0 | · | 48.3 | 44.1 | 64.5 | · | 43.0 | · | · | 41.4 | |
| EV / FCF | · | -504.4 | · | · | · | 65.9 | · | · | · | 268.6 | · | · | · | · | · | |
| EV / Revenue | 2.5 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.4 | 2.5 | 3.3 | · | 2.4 | · | · | 2.5 | |
| Earnings Yield | 0.85% | 1.5% | · | 2.7% | 3.1% | 3.1% | · | 3.1% | 3.2% | 2.5% | · | 3.8% | 3.9% | · | 4.2% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| राजस्व | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B |
| परिचालन मार्जिन % | 0.63% | 5.6% | 14.9% | 16.4% | 16.7% |
| शुद्ध आय | $-144M | $22M | $475M | $486M | $391M |
| तनुकरणित EPS | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 |
बैलेंस शीट
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| ऋण / इक्विटी | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| वर्तमान अनुपात | 1.3 | 1.4 | 1.5 | 1.3 | 1.2 |
| त्वरित अनुपात | 0.8 | 0.9 | 1.0 | 0.9 | 0.9 |
नकदी प्रवाह
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $518M | $502M | $365M | $295M | $532M |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
📊
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 616 फाइलर्स · $7.8B कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 82 (-1 पिछली तिमाही की तुलना में) | 59 (-23 पिछली तिमाही की तुलना में) | 180 (-11 पिछली तिमाही की तुलना में) | 201 (+15 पिछली तिमाही की तुलना में) | +5.0M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| FMR LLC | $737350307 | 3251247 | 9.42% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $714227026 | 3149288 | 9.12% | शेयर |
| HARRIS ASSOCIATES L P | $508269048 | 2241144 | 6.49% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $501427927 | 2210979 | 6.40% | शेयर |
| STATE STREET CORP | $422800968 | 1864284 | 5.40% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $348883077 | 1538354 | 4.46% | शेयर |
| CITADEL ADVISORS LLC | $270696771 | 1193601 | 3.46% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $259130041 | 1144937 | 3.31% | शेयर |
| EARNEST PARTNERS LLC | $254007295 | 1120011 | 3.24% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $223361616 | 984883 | 2.85% | शेयर |
| AMERIPRISE FINANCIAL INC | $192886814 | 850503 | 2.46% | शेयर |
| NEUBERGER BERMAN GROUP LLC | $192182793 | 847488 | 2.45% | शेयर |
| Clearbridge Investments, LLC | $177185527 | 781276 | 2.26% | शेयर |
| COOKE & BIELER LP | $171369328 | 755630 | 2.19% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $150762735 | 664768 | 1.93% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $110324717 | 486462 | 1.41% | शेयर |
| BANK OF AMERICA CORP /DE/ | $104921899 | 462639 | 1.34% | शेयर |
| Gotham Asset Management, LLC | $98233181 | 433146 | 1.25% | शेयर |
| Amundi | $93528650 | 412402 | 1.19% | शेयर |
| NORGES BANK | $83921372 | 370040 | 1.07% | शेयर |
| MARSHALL WACE, LLP | $76947125 | 339288 | 0.98% | शेयर |
| Iron Triangle Partners LP | $75748141 | 379728 | 0.97% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $64615913 | 374585 | 0.83% | शेयर |
| SNYDER CAPITAL MANAGEMENT L P | $63899443 | 281756 | 0.82% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $63174169 | 278558 | 0.81% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $63095473 | 278211 | 0.81% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $61384115 | 270665 | 0.78% | शेयर |
| PRIMECAP MANAGEMENT CO/CA/ | $60523448 | 266870 | 0.77% | शेयर |
| GOLDMAN SACHS GROUP INC | $57319812 | 252744 | 0.73% | शेयर |
| Meridiem Capital Partners LP | $56012367 | 246979 | 0.72% | शेयर |
| Alyeska Investment Group, L.P. | $53295650 | 235000 | 0.68% | शेयर |
| Quantinno Capital Management LP | $49020824 | 216150 | 0.63% | शेयर |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $48415129 | 213480 | 0.62% | शेयर |
| Boston Trust Walden Corp | $46506918 | 205066 | 0.59% | शेयर |
| Burgundy Asset Management Ltd. | $45453909 | 278329 | 0.58% | शेयर |
| SRS Investment Management, LLC | $42496817 | 187384 | 0.54% | शेयर |
| LOOMIS SAYLES & CO L P | $38517487 | 169838 | 0.49% | शेयर |
| JONES FINANCIAL COMPANIES LLLP | $37184513 | 172350 | 0.47% | शेयर |
| PERCEPTIVE ADVISORS LLC | $31750600 | 140000 | 0.41% | शेयर |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $30389860 | 134000 | 0.39% | शेयर |
| NEW YORK STATE COMMON RETIREMENT FUND | $29879583 | 131750 | 0.38% | शेयर |
| BlackRock, Inc. | $29025945 | 127986 | 0.37% | शेयर |
| PICTON MAHONEY ASSET MANAGEMENT | $26340305 | 116144 | 0.34% | शेयर |
| FIL Ltd | $25184576 | 111048 | 0.32% | शेयर |
| Candriam S.C.A. | $23824478 | 105152 | 0.30% | शेयर |
| Clark Capital Management Group, Inc. | $23010567 | 101462 | 0.29% | शेयर |
| Vanguard Global Advisers, LLC | $22453344 | 99005 | 0.29% | शेयर |
| Swiss National Bank | $22452210 | 99000 | 0.29% | शेयर |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | $20491384 | 90354 | 0.26% | शेयर |
| ENVESTNET ASSET MANAGEMENT INC | $20280546 | 89424 | 0.26% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19730730 | 87000 | 0.25% | कॉल ऑप्शन |
| NOMURA HOLDINGS INC | $19672672 | 86744 | 0.25% | शेयर |
| RHUMBLINE ADVISERS | $19484825 | 85916 | 0.25% | शेयर |
| Ilex Capital Partners (UK) LLP | $18413760 | 81193 | 0.24% | शेयर |
| Aristotle Capital Boston, LLC | $18273438 | 80574 | 0.23% | शेयर |
| CITADEL ADVISORS LLC | $17485509 | 77100 | 0.22% | कॉल ऑप्शन |
| NICHOLAS COMPANY, INC. | $16305067 | 71895 | 0.21% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $15172024 | 66899 | 0.19% | शेयर |
| Mitsubishi UFJ Asset Management Co., Ltd. | $15164087 | 66864 | 0.19% | शेयर |
| Ranger Investment Management, L.P. | $15009416 | 66182 | 0.19% | शेयर |
| California Public Employees Retirement System | $14670818 | 64689 | 0.19% | शेयर |
| Assenagon Asset Management S.A. | $14020385 | 61821 | 0.18% | शेयर |
| ASSETMARK, INC | $13939194 | 61463 | 0.18% | शेयर |
| Rhenman & Partners Asset Management AB | $12972388 | 57200 | 0.17% | शेयर |
| RIVERBRIDGE PARTNERS LLC | $12859587 | 56703 | 0.16% | शेयर |
| TD Asset Management Inc | $12854230 | 56679 | 0.16% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $12836314 | 56600 | 0.16% | पुट ऑप्शन |
| Laurus Investment Counsel Inc. | $12365663 | 71685 | 0.16% | शेयर |
| KING LUTHER CAPITAL MANAGEMENT CORP | $12204023 | 53812 | 0.16% | शेयर |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $11552133 | 50938 | 0.15% | शेयर |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $10732081 | 47278 | 0.14% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $10506727 | 46328 | 0.13% | शेयर |
| VANGUARD ASSET MANAGEMENT, Ltd | $10472482 | 46177 | 0.13% | शेयर |
| KENNEDY CAPITAL MANAGEMENT LLC | $9914950 | 43719 | 0.13% | शेयर |
| BARCLAYS PLC | $9909816 | 43696 | 0.13% | शेयर |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $9827670 | 56972 | 0.13% | शेयर |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $9382529 | 41371 | 0.12% | शेयर |
| Park West Asset Management LLC | $9343748 | 41200 | 0.12% | शेयर |
| State of Tennessee, Department of Treasury | $8457000 | 37290 | 0.11% | शेयर |
| J.P. Marvel Investment Advisors, LLC | $8456092 | 37286 | 0.11% | शेयर |
| CASTLEARK MANAGEMENT LLC | $8174646 | 36045 | 0.10% | शेयर |
| JANE STREET GROUP, LLC | $7869613 | 34700 | 0.10% | कॉल ऑप्शन |
| Pine Ridge Advisers LLC | $7710860 | 34000 | 0.10% | शेयर |
| PRUDENTIAL FINANCIAL INC | $7346635 | 32394 | 0.09% | शेयर |
| Capricorn Fund Managers Ltd | $7092630 | 31274 | 0.09% | शेयर |
| STATE OF WISCONSIN INVESTMENT BOARD | $7000554 | 30868 | 0.09% | शेयर |
| FIRST TRUST ADVISORS LP | $6951290 | 30651 | 0.09% | शेयर |
| Caption Management, LLC | $6803700 | 30000 | 0.09% | पुट ऑप्शन |
| Engineers Gate Manager LP | $6637463 | 29267 | 0.08% | शेयर |
| LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE | $6351027 | 28004 | 0.08% | शेयर |
| Midwest Trust Co | $6091126 | 26858 | 0.08% | शेयर |
| VAN ECK ASSOCIATES CORP | $5942578 | 26203 | 0.08% | शेयर |
| SEI INVESTMENTS CO | $5929630 | 26150 | 0.08% | शेयर |
| Sendero Wealth Management, LLC | $5909468 | 26057 | 0.08% | शेयर |
| 13D Management LLC | $5851182 | 25800 | 0.07% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $5500853 | 31889 | 0.07% | शेयर |
| D. E. Shaw & Co., Inc. | $5462691 | 24087 | 0.07% | शेयर |
| INVESTMENT HOUSE LLC | $5447042 | 24018 | 0.07% | शेयर |
| LPL Financial LLC | $5409169 | 23851 | 0.07% | शेयर |
| LRT Capital Management, LLC | $5348842 | 23585 | 0.07% | शेयर |
कंपनी के अंदरूनी सूत्र 57 इनसाइडर्स · 21 अधिकारी · 27 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Glenn Coleman | EVP & Chief Financial Officer | 29 मई 2026 A | 27752 | 0 | 0 | $0 |
| Flavia Pease | Corporate Executive VP & CFO | 31 मई 2025 F | 17297 | 0 | 0 | $0 |
| David Ross Smith | Corporate Executive VP & CFO | 3 मार्च 2022 M | 25819 | 0 | 0 | $0 |
| Davide Molho | President & COO | 24 जुलाई 2018 M | 17155 | 0 | 0 | $0 |
| Mark Mintz | EVP, Chief Information Officer | 31 मई 2026 F | 9546 | 0 | 0 | $0 |
| William D Barbo | Corporate Executive VP & CCO | 7 नवमबर 2024 G | 23337 | 0 | 0 | $0 |
| John W Kuo | CEVP General Counsel & CCO | 1 जून 2020 A | 3171 | 0 | 0 | $0 |
| David P Johst | Corporate Executive VP | 29 मई 2020 A | 224478 | 0 | 0 | $0 |
| John J Crowley | SVP, Chief Accounting Officer | 1 अक्टूबर 2016 F | 5599 | 0 | 0 | $0 |
| Nancy Gillett | Corporate Executive VP | 2 मार्च 2016 S | 11034 | 0 | 0 | $0 |
| Jorg Geller | Corporate Executive VP | 25 फ़रवरी 2015 M | 14094 | 0 | 0 | $0 |
| RENAUD REAL H | Corp. Executive VP | 11 अगस्त 2010 F | 74390 | 0 | 0 | $0 |
| Christopher Berthoux | Executive Vice President | 26 फ़रवरी 2010 A | 31897 | 0 | 0 | $0 |
| Joanne P Acford | Corp. Sr VP, GC and Corp. Sec | 11 अगस्त 2007 F | 37109 | 0 | 0 | $0 |
| David J Elliott | Officer | 29 जून 2007 M | 11750 | 0 | 0 | $0 |
| Cheri L Walker | Corporate Senior VP | 1 मई 2007 A | 6262 | 0 | 0 | $0 |
| Stephanie B Wells | Senior Vice President | 2 अप्रैल 2007 A | 11500 | 0 | 0 | $0 |
| Nicholas Ventresca | Senior Vice President | 2 अप्रैल 2007 F | 12713 | 0 | 0 | $0 |
| John C Ho | Senior Vice President | 23 फ़रवरी 2007 A | 12710 | 0 | 0 | $0 |
| Brian Bathgate | Corporate Vice President | 27 फ़रवरी 2006 S | 16134 | 0 | 0 | $0 |
| Alastair Stuart Mcewan | Corporate VP | 23 दिसमबर 2004 M | 8000 | 0 | 0 | $0 |
| Steven Barg | निदेशक | 2 जून 2026 A | 3287 | 0 | 0 | $0 |
| Nancy C Andrews | निदेशक | 12 मई 2026 G | 3964 | 0 | 0 | $0 |
| Reshema Kemps-Polanco | निदेशक | 8 मई 2026 A | 4563 | 0 | 0 | $0 |
| George Llado | निदेशक | 8 मई 2026 A | 6702 | 0 | 0 | $0 |
| Abraham Ceesay | निदेशक | 8 मई 2026 A | 2384 | 0 | 0 | $0 |
| Mark J Enyedy | निदेशक | 8 मई 2026 A | 2384 | 0 | 0 | $0 |
| Paul W Graves | निदेशक | 8 मई 2026 A | 2384 | 0 | 0 | $0 |
| Craig B. Thompson | निदेशक | 8 मई 2026 A | 3851 | 0 | 0 | $0 |
| Martin Mackay | निदेशक | 8 मई 2026 A | 17137 | 0 | 0 | $0 |
| Virginia M Wilson | निदेशक | 8 मई 2026 A | 6349 | 0 | 0 | $0 |
| George Massaro | निदेशक | 15 मई 2025 S | 5575 | 0 | 0 | $0 |
| Richard F Wallman | निदेशक | 7 नवमबर 2024 S | 0 | 0 | 0 | $0 |
| Deborah Turner Kochevar | निदेशक | 13 मई 2024 A | 7894 | 0 | 0 | $0 |
| Robert J Bertolini | निदेशक | 13 मई 2024 A | 32802 | 0 | 0 | $0 |
| Richard C Reese | निदेशक | 15 मई 2023 A | 65541 | 0 | 0 | $0 |
| George M Milne JR | निदेशक | 7 मई 2021 A | 29079 | 0 | 0 | $0 |
| Stephen D Chubb | निदेशक | 23 फ़रवरी 2021 M | 40529 | 0 | 0 | $0 |
| Jean-Paul Mangeolle | निदेशक | 22 मई 2019 A | 3886 | 0 | 0 | $0 |
| William Waltrip | निदेशक | 5 दिसमबर 2012 S | 21830 | 0 | 0 | $0 |
| Samuel O Thier MD | निदेशक | 9 मई 2012 A | 18230 | 0 | 0 | $0 |
| Douglas E Rogers | निदेशक | 7 मई 2010 A | 12859 | 0 | 0 | $0 |
| Nancy T Chang | निदेशक | 7 मई 2010 A | 31010 | 0 | 0 | $0 |
| Linda Mcgoldrick | निदेशक | 13 फ़रवरी 2006 A | — | 0 | 0 | $0 |
| Walter S Nimmo | निदेशक | 25 फ़रवरी 2005 S | 149447 | 0 | 0 | $0 |
| John Urquhart | निदेशक | 17 फ़रवरी 2005 A | 11738 | 0 | 0 | $0 |
| Louise S Mccrary | निदेशक | 17 फ़रवरी 2005 A | — | 0 | 0 | $0 |
| Robert Cawthorn | निदेशक | 2 जून 2004 G | 278600 | 0 | 0 | $0 |
| Shannon M Parisotto | — | 11 अगस्त 2026 M | 4807 | 0 | 2 | $-2365755 |
| Birgit Girshick | — | 11 अगस्त 2026 M | 36013 | 0 | 1 | $-1819350 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 6 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| JANA PARTNERS LLC ×4 फाइलिंग | 4 अगस्त 2011 | — | प्रारंभिक फाइलिंग | — | SEC |
| Relational Investors, LLC, Relational Investors Mid-Cap Fund I, L.P., Relational Investors Mid-Cap Fund II, L.P., Ralph V. Whitworth, David H. Batchelder, California State Teachers’ Retirement System ×3 फाइलिंग | 9 फ़रवरी 2011 | — | प्रारंभिक फाइलिंग | — | SEC |
| Neuberger Berman Group LLC, Neuberger Berman LLC, Neuberger Berman Management ×3 फाइलिंग | 7 दिसमबर 2010 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 16 जून 2010 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 7 जून 2010 | — | प्रारंभिक फाइलिंग | निष्क्रिय निवेश | SEC |
| Charles River Laboratories International, Inc. IRS No. 061397316 | 5 मई 2010 | — | प्रारंभिक फाइलिंग | बोर्ड अभियान | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 135 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 2.18% | 63652 SH | 8 अगस्त 2026 | दैनिक |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.49% | 4749 NS | 30 अप्रैल 2026 | N-PORT |
| EPSB · Harbor ETF Trust | 1.33% | 370 NS | 30 अप्रैल 2026 | N-PORT |
| SPHB · Invesco Exchange-Traded Fund Trust … | 1.18% | 41597 SH | 8 अगस्त 2026 | दैनिक |
| EPMV · Harbor ETF Trust | 1.09% | 291 NS | 30 अप्रैल 2026 | N-PORT |
| IBB · iShares Trust | 0.97% | 349491 SH | 8 अगस्त 2026 | दैनिक |
| EPSV · Harbor ETF Trust | 0.90% | 270 NS | 30 अप्रैल 2026 | N-PORT |
| TAX · EA Series Trust | 0.80% | 1131 NS | 29 मई 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.66% | 612 NS | 30 अप्रैल 2026 | N-PORT |
| HIBL · Direxion Shares ETF Trust | 0.50% | 2356 NS | 30 अप्रैल 2026 | N-PORT |
| ISCV · iShares Trust | 0.40% | 10497 SH | 8 अगस्त 2026 | दैनिक |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.38% | 11925 NS | 30 अप्रैल 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.38% | 25401 SH | 8 अगस्त 2026 | दैनिक |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0.36% | 1145000 PA | 8 अगस्त 2026 | दैनिक |
| IQSM · New York Life Investments ETF Trust | 0.33% | 6161 NS | 30 अप्रैल 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.29% | 22440 NS | 30 अप्रैल 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.27% | 996151 SH | 8 अगस्त 2026 | दैनिक |
| DFAT · Dimensional ETF Trust | 0.26% | 212321 NS | 30 अप्रैल 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.23% | 701498 SH | 8 अगस्त 2026 | दैनिक |
| ESML · iShares Trust | 0.23% | 24979 SH | 8 अगस्त 2026 | दैनिक |
| BKMC · BNY Mellon ETF Trust | 0.22% | 8115 NS | 30 अप्रैल 2026 | N-PORT |
| IYH · iShares Trust | 0.21% | 29370 SH | 8 अगस्त 2026 | दैनिक |
| ISCB · iShares Trust | 0.20% | 2125 SH | 8 अगस्त 2026 | दैनिक |
| SMMD · iShares Trust | 0.17% | 24455 SH | 8 अगस्त 2026 | दैनिक |
| FSMD · FIDELITY COVINGTON TRUST | 0.17% | 24528 NS | 30 अप्रैल 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.17% | 133341 NS | 31 मई 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.16% | 138243 NS | 30 अप्रैल 2026 | N-PORT |
| IXJ · iShares Trust | 0.16% | 25598 SH | 8 अगस्त 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.16% | 148331 SH | 8 अगस्त 2026 | दैनिक |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 18369 NS | 30 अप्रैल 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.15% | 6079 NS | 31 मई 2026 | N-PORT |
| WSML · iShares Trust | 0.13% | 6018 SH | 8 अगस्त 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.13% | 22674 NS | 30 अप्रैल 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.13% | 59338 NS | 30 अप्रैल 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.13% | 1102914 SH | 8 अगस्त 2026 | दैनिक |
| VGMS · VANGUARD MALVERN FUNDS | 0.13% | 315000 PA | 8 अगस्त 2026 | दैनिक |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.13% | 4072 SH | 8 अगस्त 2026 | दैनिक |
| RXL · ProShares Trust | 0.13% | 513 NS | 31 मई 2026 | N-PORT |
| IWS · iShares Trust | 0.13% | 74284 SH | 8 अगस्त 2026 | दैनिक |
| REVS · Columbia ETF Trust I | 0.12% | 2082 NS | 30 अप्रैल 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.12% | 982 NS | 30 अप्रैल 2026 | N-PORT |
| SMLF · iShares Trust | 0.12% | 18532 SH | 8 अगस्त 2026 | दैनिक |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.11% | 3280 NS | 30 अप्रैल 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 0.11% | 1032 NS | 30 अप्रैल 2026 | N-PORT |
| IWR · iShares Trust | 0.09% | 199595 SH | 8 अगस्त 2026 | दैनिक |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.09% | 1986 NS | 31 मई 2026 | N-PORT |
| IEUS · iShares Trust | 0.09% | 4951 SH | 8 अगस्त 2026 | दैनिक |
| XOEF · iShares Trust | 0.07% | 61 SH | 8 अगस्त 2026 | दैनिक |
| VSDB · VANGUARD MALVERN FUNDS | 0.07% | 635000 PA | 8 अगस्त 2026 | दैनिक |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.07% | 5261 NS | 30 अप्रैल 2026 | N-PORT |